The effectiveness of shoulder injections

Not Applicable

Completed

Conditions: Shoulder disorders, complaints of shoulder, painful arc
Musculoskeletal Diseases
Other joint disorders, not elsewhere classified

Registration Number: ISRCTN51511455

Lead Sponsor: Care and Public Health Research Institute (CAPHRI) (The Netherlands)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Completed

Sex: All

Target Recruitment: 159

Inclusion Criteria

1. Patients 18 years of age and older
2. Consult a physician for pain in the shoulder either at rest or elicited or provoked during movement of the shoulder
3. Must have a painful arc, with or without a disturbed scapulohumeral movement. The diagnosis is subacromial impingement syndrome.

Exclusion Criteria

1. Pain lasting less than 6 weeks
2. Prior injection with corticosteroids last 3 months, less than 100 degrees range of ante-flexion
3. More than 50% restriction of external glenohumeral rotation (compared to the non-affected side)
4. Steroid or lidocaine allergy
5. Pregnancy or supposed pregnancy
6. Dementia
7. (Prior) purulent infection of the shoulder joints
8. Tumour, osteoporosis, rheumatoid arthritis (American College of Rheumatology [ACR] criteria), referred pain from internal organs, or a cervical radicular syndrome as suspected or definite cause for SD
9. Stroke, polyneuropathy, multiple sclerosis, polymyalgia, ankylosing spondylitis (modified NY criteria) as suspected or definite cause for SD
10. Whiplash, prior fractures or surgery of the shoulder, upper limb, neck or thorax
11. Currently receiving (or needing) treatment for serious behavioral, cognitive or psychiatric disorders
12. Not able to complete Dutch questionnaires independently and those who are reluctant to adhere to (allocated) treatments or to complete follow-up will be excluded

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
At 3, 6, 12 and 26 weeks after the inclusion: patient-perceived recovery measured with a Visual Analogue Scale (VAS) expressed as the proportion of patients indicating very large improvement (including full recovery). The Visual Analogue Scale is a line of 10 cm in length, which is taken to represent the continuum of experienced pain. It has been proved to be a simple, sensitive and reproducible instrument that enables the patient to express the pain in such a way that it can be given a numerical value.

Secondary Outcome Measures